Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer


Yazar A.

advances in modern oncology research, cilt.3, ss.223-231, 2017 (ESCI İndekslerine Giren Dergi)

  • Cilt numarası: 3 Konu: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.18282/amor.v3.i5.212
  • Dergi Adı: advances in modern oncology research
  • Sayfa Sayısı: ss.223-231